AI医疗自动化技术研究商Coral获得1250万美元融资，通过与传真机合作而非对抗，实现医疗保健后勤办公室的自动化

In American healthcare, the most common reason a patient waits is not clinical. Referrals stall in fax queues. Prior authorizations sit unresolved. Discharges are delayed because paperwork has not been processed. The bottleneck is not a shortage of doctors. There is a shortage of people to handle the administrative work that comes before and after every appointment..

在美国医疗保健体系中，患者等待的最常见原因并非临床因素。转诊单滞留在传真队列中。事先授权尚未解决。出院因文书工作未处理而延误。瓶颈不是医生短缺，而是每个预约前后处理行政工作的人员不足。

Coral

珊瑚

was built to change that. Today, the company announced a $12.5 million investment led by Lightspeed and Z47. The company was founded by Ajay Shrihari and Aniket Mohanty.

旨在改变这一现状。今天，该公司宣布了由Lightspeed和Z47领投的1250万美元投资。公司由Ajay Shrihari和Aniket Mohanty创立。

For Ajay, the problem was not abstract. A minor accident sent him through the US healthcare system as a patient for the first time, and what followed was instructive. The clinical care was not the issue. Everything surrounding it was: follow-up calls that went unanswered for days, paperwork that outlasted the injury itself.

对于阿贾伊来说，这个问题并不是抽象的。一次小事故让他首次作为患者经历了美国的医疗系统，接下来的经历颇有启发性。临床护理本身不是问题，围绕它的一切才是：连续数天无人接听的后续电话、比伤情本身持续时间还长的文书工作。

Coral was the answer the two of them built to that experience..

珊瑚是他们两人针对那次经历所构建的答案。

Coral’s founding insight was simple. Do not replace the fax. Automate around it. Instead of asking providers to rebuild their infrastructure, Coral connects to existing EHR systems, fax lines, and payer portals and automates end-to-end administrative workflows for specialty healthcare providers, including DME suppliers, infusion centers, and radiology practices.

Coral的创立理念很简单：不要取代传真，而是围绕它实现自动化。Coral并不要求供应商重建其基础设施，而是连接到现有的电子健康记录（EHR）系统、传真线路和支付方门户，并为专业医疗供应商（包括耐用医疗设备供应商、输液中心和放射科诊所）自动执行端到端的管理流程。

The platform handles intake, prior authorization, fax processing, and patient communications without requiring providers to change how they work..

该平台处理接收、事先授权、传真处理和患者沟通，而无需提供商改变他们的工作方式。

Coral’s models have now reached 99.7% accuracy on the document types that define healthcare’s back office: handwritten fax forms, scanned insurance cards, prior authorization templates, payer portal screens. Complete patient intakes, including the most complex cases the platform handles, now run in under five minutes, and when the information is missing, which happens frequently, Coral can seamlessly work with all the relevant parties to get information and process a patient’s case..

Coral的模型在定义医疗后台办公的文档类型上现已达到99.7%的准确率：手写传真表格、扫描的保险卡、预先授权模板、支付门户屏幕。完整的患者录入，包括平台处理的最复杂案例，现在运行时间不到五分钟，当信息缺失时（这是经常发生的），Coral可以无缝地与所有相关方合作获取信息并处理患者的案例。

Ajay Shrihari, Founder and CEO, Coral

Ajay Shrihari，Coral创始人兼首席执行官

said: “Every person in the healthcare system is being slowed down by the same thing: administrative work that was never built to scale. The coordinator chasing faxes. The patient waiting on a referral. The clinician buried in prior authorizations. When you automate the right things, all of them win at once.

说：“医疗保健系统中的每个人都在被同一件事拖慢速度：从未能规模化构建的行政工作。协调员在追传真。患者在等待转诊。临床医生被事先授权淹没。当你自动化处理正确的事情时，所有人都会同时受益。”

That is what Coral is building, and we are just getting started.”.

这就是Coral正在构建的，而我们才刚刚开始。

Coral began by serving durable medical equipment (DME) providers, proving the model in one of the most fax-intensive corners of outpatient care. As it scaled, the same pattern appeared across every new specialty it entered. The administrative bottleneck was not a DME problem. It was a healthcare problem..

Coral最初服务于耐用医疗设备（DME）供应商，在门诊护理中传真的高频率领域验证了这一模式。随着规模扩大，它进入的每一个新专业领域都出现了相同的情况。行政瓶颈并非DME问题，而是整个医疗保健领域的问题。

For infusion patients, a treatment delay is not an inconvenience. It is a missed dose. Coral has deployed its platform across infusion centres, handling the authorization and intake workflows that previously kept clinical staff from patients for hours at a time.

对于输液患者来说，治疗延误不是一种不便，而是一次错过的剂量。Coral 已经在输液中心部署了其平台，处理之前让临床工作人员长时间无法接触患者的授权和接收工作流程。

The strongest signal of customer confidence is not a case study but what customers choose to hand Coral next. A growing number are now running multiple modules across their operations, and a portion are paying the full contract value upfront, an unusual dynamic in enterprise software and a particularly striking one in a sector where vendor evaluation cycles are notoriously long.

客户信心的最强烈信号不是案例研究，而是客户接下来选择交给Coral的内容。越来越多的客户正在其运营中运行多个模块，其中一部分甚至提前支付全额合同费用，这在企业软件领域是一种不寻常的动态，而在供应商评估周期以漫长著称的行业中，这一现象尤为引人注目。

The calculation is straightforward: when a complex workflow completes in under five minutes at high accuracy, the return is immediate enough that the commitment follows..

计算很简单：当一个复杂的工作流程在五分钟内以高精度完成时，回报立竿见影，承诺也随之而来。

Coral has reached multiple millions in revenues and is targeting 4x growth before the end of the year, expanding further across existing verticals while moving into radiology and additional specialty categories.

Coral 的收入已达数百万，并计划在年底前实现 4 倍增长，同时将进一步扩展现有垂直领域并进军放射学和其他专科类别。

Rohil Bagga, Investor at Lightspeed

罗希尔·巴嘎，光速创投的投资人

added: “Healthcare is one of the hardest environments to automate, given legacy systems and fragmented workflows, yet Coral is delivering real outcomes at scale. Their product is already being used by some of the largest customers in the U.S. to dramatically reduce patient intake times and first-pass denials.

补充道：“鉴于传统的系统和分散的工作流程，医疗保健是自动化最难的环境之一，但Coral却在大规模地交付实际成果。他们的产品已经被美国一些最大的客户使用，大幅减少了患者入院时间和初次拒绝的情况。”

At Lightspeed, we’ve had the privilege of being part of Coral’s journey since day one, and we’re excited to continue supporting the team as they transform the healthcare industry”.

在光速创投，我们有幸从第一天起就参与了Coral的旅程，并且随着他们变革医疗行业，我们将继续支持这支团队。

Ashwin KP, Investor at Z47

阿什温·KP，Z47投资者

commented: “US healthcare admin carries over a trillion dollars in overhead each year, yet the back-office teams doing this work have been chronically underserved by technology. Our thesis is that the most compelling AI opportunities lie in workflow-heavy, tech-underserved categories that demand deep vertical expertise to crack.

评论道：“美国医疗保健管理每年承担超过一万亿美元的开销，但从事这项工作的后勤团队长期以来在技术方面服务不足。我们的观点是，最引人注目的人工智能机会存在于那些工作流程繁重、技术供应不足且需要深厚垂直领域专业知识才能解决的类别中。”

Ajay and Aniket are exceptionally customer-obsessed founders who embedded themselves with these teams, understood their pain at a granular level, and built a product their customers can’t live without. The rapid growth and the caliber of customers they’ve won in a short time only reinforced our conviction.

Ajay和Aniket是极其以客户为中心的创始人，他们深入这些团队，细致入微地理解他们的痛点，并打造了一款客户不可或缺的产品。他们在短时间内实现的快速增长和赢得的高质量客户，进一步坚定了我们的信念。

We’re privileged to partner with them.”.

我们很荣幸能与他们合作。

The round goes toward team and product. Coral is adding engineering talent alongside people who have spent careers inside healthcare operations, builders and industry experts working in the same room for the first time in this category.

这一轮走向团队和产品。Coral 正在增加工程人才，与那些在医疗运营领域度过职业生涯的人、建设者和行业专家并肩工作，这是他们首次在这个类别中同处一室。

On the product side, the company recently shipped AI-powered voice and text workflows, automating follow-ups with payers, patients, and referral sources that would previously require a staff member to pick up the phone. The next phase goes further. Coral is building an AI workflow builder that lets providers design and deploy their own administrative workflows without raising an IT ticket, adapting Coral to the way their operations actually run rather than the other way around..

在产品方面，该公司最近推出了由人工智能驱动的语音和文本工作流程，自动跟进支付方、患者和转诊来源，而以往这些工作需要员工打电话完成。下一阶段将进一步深化。Coral正在构建一个AI工作流生成器，让医疗服务提供者能够自行设计和部署他们的管理流程，而无需提交IT工单，使Coral适应其实际运营方式，而非反过来要求运营适应Coral。

Alongside that, Coral is developing what it describes as a co-pilot layer for the business: a way to surface intelligence from the data it already processes. Which payers have the highest denial rates and what the common rejection reasons are. Where in the authorization process cases are stalling. Which referral sources convert to completed intakes and which do not.

与此同时，Coral 正在开发其所谓的业务“副驾”层：一种从其已处理的数据中提取智能的方法。哪些支付方的拒绝率最高，常见的拒绝原因是什么。授权流程中哪些环节案件被搁置。哪些转诊来源转化为已完成的接收，哪些没有。

Where revenue is being stopped by insurance claim rejections, and what would change the outcome on resubmission. The ambition is that a practice manager can ask Coral what is slowing their operation down and get a specific, actionable answer, not a report to interpret but a clear next step..

保险索赔被拒导致收入受阻的地方，以及重新提交后会改变结果的因素。目标是让诊所经理可以询问Coral是什么在拖慢他们的运营，并得到一个具体且可操作的答案，而不是一份需要解读的报告，而是一个明确的下一步行动。

The system is not going to simplify itself. Coral’s answer is that administration is a workflow problem, not a staffing one. Across DME, infusion, and specialty pharmacy, that answer is proving out. The fax queue gets shorter. Staff get to spend their time on patients.

系统本身不会自动简化。Coral 的答案是，管理是一个工作流程问题，而不是人员配置问题。在 DME、输液和专业药房领域，这个答案正在得到验证。传真队列变得更短了，员工可以将时间花在病人身上。